Boothbay Fund Management’s Abeona Therapeutics ABEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $117K | Sell |
20,586
-197,820
| -91% | -$1.12M | ﹤0.01% | 1105 |
|
|
2025
Q1 | $1.04M | Sell |
218,406
-59,179
| -21% | -$282K | 0.03% | 487 |
|
|
2024
Q4 | $1.55M | Buy |
277,585
+56,048
| +25% | +$312K | 0.04% | 427 |
|
|
2024
Q3 | $1.4M | Sell |
221,537
-12,295
| -5% | -$77.7K | 0.03% | 533 |
|
|
2024
Q2 | $991K | Sell |
233,832
-36,508
| -14% | -$155K | 0.02% | 616 |
|
|
2024
Q1 | $1.96M | Buy |
270,340
+110,080
| +69% | +$798K | 0.04% | 437 |
|
|
2023
Q4 | $803K | Buy |
+160,260
| New | +$803K | 0.02% | 676 |
|
|
2021
Q3 | – | Sell |
-991
| Closed | -$39K | – | 1612 |
|
|
2021
Q2 | $39K | Buy |
+991
| New | +$39K | ﹤0.01% | 1607 |
|
|
2020
Q1 | – | Sell |
-400
| Closed | -$33K | – | 723 |
|
|
2019
Q4 | $33K | Buy |
+400
| New | +$33K | ﹤0.01% | 709 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 601 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 563 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 614 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 505 |
|